Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX |
|
Open Access Green as soon as Postprint is submitted to ZB.
Response to Neoadjuvant Chemotherapy Combined with Regional Hyperthermia Predicts Long-Term Survival for Adult Patients with Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas.
J. Clin. Oncol. 20, 3156-3164 (2002)
Purpose: To determine the efficacy of neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for local tumor control and overall survival (OS) in adult patients with retroperitoneal or visceral (RP/V) high-risk soft tissue sarcomas (HR-STS).Patients and Methods: From 1991 to 1997, 58 patients with HR-STS at RP/V sites were prospectively treated with four cycles of etoposide, ifosfamide, and doxorubicin combined with RHT followed by surgery, adjuvant chemotherapy, and radiation.
Impact Factor
Scopus SNIP
8.530
0.000
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
PROGNOSTIC FACTORS; PHASE-II; PREOPERATIVE CHEMOTHERAPY; RADIOTHERAPY; RECURRENT; EXTREMITY; HEAT; TRIAL; MANAGEMENT; RADIATION
Language
english
Publication Year
2002
HGF-reported in Year
0
ISSN (print) / ISBN
0732-183X
e-ISSN
1527-7755
Quellenangaben
Volume: 20,
Pages: 3156-3164
Publisher
American Society of Clinical Oncology
Reviewing status
Peer reviewed
Institute(s)
CCG Tumor Therapy with Hyperthermia (IMI-KTH)
POF-Topic(s)
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s)
Immune Response and Infection
PSP Element(s)
G-521100-001
Erfassungsdatum
2002-09-09